Skip to main content
Search

University Hospital Heidelberg

6 related articles

Subscribe to updates
  1. Nature

    Glioblastoma's malignant states are not scattered at random: a developmental-to-injury-and-hypoxia trajectory layers around the necrotic core

    Glioblastoma malignant states were treated as parallel subtypes, and a single biopsy could not represent the whole tumour. Pairing single-nucleus and spatial transcriptomics across 12 IDH-wild-type primary tumours and 57 sampling sites revealed a trajectory from developmental-like states toward glial injury response and hypoxia, layered in space from the infiltrating edge to the necrotic core; the trajectory appears across tumour subtypes and genetically distinct subclones and is recapitulated in patient-derived organoids.

  2. medRxiv

    Ewing sarcoma survival splits by neighborhood, not mutation: a 135-patient spatial map yields four prognostic types, with interferon-reactive tumors faring best

    Ewing sarcoma is genomically near-uniform yet patients fare very differently. Single-cell and spatial transcriptomics of tumors and their microenvironment in 135 patients identified five tumor-cell transcriptional states and eight niches defined by neighboring cell configurations, and niche composition sorted patients into Fusion Active, Proliferative, Immune Reactive and TME-enriched types. The Immune Reactive type, marked by interferon-activated tumor cells, had favorable survival, and the survival differences reproduced in two independent bulk transcriptomic cohorts.

  3. Standard pipeline called these tumors PTEN wild-type; a gradient-boosting model found 33 more deletions, and 75% of stainable cases lost the protein

    At the Dresden University Cancer Center's MASTERsg precision oncology program, a gradient-boosting model re-reads the raw bin-level copy-number data from TSO500 panel sequencing to find focal PTEN deletions that the standard pipeline misses. TSO500 averages read counts across bins within a gene, so focal events fall short of its fold-change threshold; the model flagged deletions in 33 of 204 samples classified as PTEN wild-type, and 15 of the 20 stainable cases showed absent or reduced PTEN protein.

  4. SpaCEy links tissue spatial patterns to clinical outcomes with an explainable graph neural network, improving prediction and surfacing spatial markers in lung and breast cancer cohorts

    The authors present SpaCEy (Spatial Clinical Explainability), an explainable graph neural network that builds each tissue sample into a spatial graph via Delaunay triangulation, with nodes as single-cell protein-marker abundances and no predefined cell-type or anatomical-region inputs, learns predictive embeddings with a GNN, and uses a GNNExplainer-style explainer to output edge masks that are aggregated over k-hop neighbourhoods into node importance, thereby localising contiguous outcome-associated spatial regions and key proteins; it predicted progression in a 416-patient lung adenocarcinoma cohort (accuracy 0.68, F1 0.68, AUC 0.62, versus Ali et al. 0.61/0.59/0.57 and SPACE-GM 0.55/0.52/0.

  5. arXiv

    Replacing human labels with seven models across four abdominal CT datasets removed pretraining's dependence on label quality while direct deployment stayed quality-sensitive

    Across four abdominal CT datasets (WORD, AMOS, CT-1K, AbdomenAtlas), the authors generated pseudo-label variants with seven models (nnU-Net, MedSAM, TotalSegmentator, and four STU-Net sizes), then trained DynUNet under identical deterministic settings for in-domain training and for pretraining followed by fine-tuning; in-domain performance rose strongly and non-linearly with label quality and dataset volume partly compensated for quality, whereas fine-tuned models significantly outperformed a no-pretrain baseline in the vast majority of settings and pretraining label quality no longer clearly affected downstream results.

  6. On-Premise Detection of a Guideline-Driven Oral Anticoagulation Shift in German Doctors' Letters Using Local Large Language Models

    Using an on-premise fine-tuned Llama-3.1-70b medication information extraction pipeline, the study automatically extracted medication information from 538 unannotated routine 2012 doctors' letters and compared them with 500 CARDIO:DE letters from 2020/21 (using gold-standard annotations), finding that the DOAC proportion rose from 16.9% to 59.9% while the VKA proportion fell from 37.7% to 9.9%, that the dominant active ingredient within DOACs shifted from rivaroxaban to apixaban, and that manual review showed remaining errors were mainly linked to generic medication mentions and missing medication-reason relations rather than incorrect extraction.

You’re all caught up